301087 可孚医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.8927.6916.4315.1276.053
总资产报酬率 ROA (%)2.8725.6944.9224.0194.938
投入资产回报率 ROIC (%)3.2696.3945.4404.5205.523

边际利润分析
销售毛利率 (%)55.88853.16351.85743.27839.513
营业利润率 (%)11.79712.66612.51510.32812.375
息税前利润/营业总收入 (%)12.31512.48311.7069.34410.114
净利润/营业总收入 (%)9.80810.93210.4718.86110.145

收益指标分析
经营活动净收益/利润总额(%)92.51881.88394.69790.76098.887
价值变动净收益/利润总额(%)6.00715.4255.84516.15418.288
营业外收支净额/利润总额(%)-0.141-0.752-0.351-3.157-10.173

偿债能力分析
流动比率 (X)2.6302.4142.8833.5263.537
速动比率 (X)2.1841.9892.3982.9423.091
资产负债率 (%)25.40726.03825.22821.39621.494
带息债务/全部投入资本 (%)13.75913.91715.15410.5537.477
股东权益/带息债务 (%)612.219601.565544.739821.4871,199.099
股东权益/负债合计 (%)291.688281.969296.028366.707364.338
利息保障倍数 (X)23.053-141.542-15.296-13.988-9.045

营运能力分析
应收账款周转天数 (天)34.49441.38251.17765.62255.172
存货周转天数 (天)144.098151.465162.229129.449100.973